Towards host-directed therapies for tuberculosis

Alimuddin Zumla; Markus Maeurer; Jeremiah Chakaya; Michael Hoelscher; Francine Ntoumi; Roxana Rustomjee; Cristina Vilaplana; Dorothy Yeboah-Manu; Voahangy Rasolofo; Paula Munderi; Nalini Singh; Eleni Aklillu; Nesri Padayatchi; Eusebio Macete; Nathan Kapata; Modest Mulenga; Gibson Kibiki; Sayoki Mfinanga; Thomas Nyirenda; Leonard Maboko; Alberto Garcia-Basteiro; Niaina Rakotosamimanana; Matthew Bates; Peter Mwaba; Klaus Reither; Sebastien Gagneux; Sarah Edwards; Elirehema Mfinanga; Salim Abdulla; Pere Joan Cardona; James B.W. Russell; Vanya Gant; Mahdad Noursadeghi; Paul Elkington; Maryline Bonnet; Clara Menendez; Tandakha N. Dieye; Bassirou Diarra; Almoustapha Maiga; Abraham Aseffa; Shreemanta Parida; Christian Wejse; Eskild Petersen; Pontiano Kaleebu; Matt Oliver; Gill Craig; Tumena Corrah; Leopold Tientcheu; Martin Antonio; Martin Rao; Timothy D. McHugh; Aziz Sheikh; Giuseppe Ippolito; Gita Ramjee; Stefan H.E. Kaufmann; Gavin Churchyard; Andrie Steyn; Martin Grobusch; Ian Sanne; Neil Martinson; Rajhmun Madansein; Robert J. Wilkinson; Bongani Mayosi; Marco Schito; Robert S. Wallis

Article

Towards host-directed therapies for tuberculosis

Nature Reviews Drug Discovery

DOI: 10.1038/nrd4696

118Citations

243Readers

Get full text

Abstract

The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.

Cite

CITATION STYLE

APA

Zumla, A., Maeurer, M., Chakaya, J., Hoelscher, M., Ntoumi, F., Rustomjee, R., … Wallis, R. S. (2015, August 1). Towards host-directed therapies for tuberculosis. Nature Reviews Drug Discovery. Nature Publishing Group. https://doi.org/10.1038/nrd4696

Towards host-directed therapies for tuberculosis

Abstract

Cite

Register to see more suggestions